News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Indiana’s first mobile lung screening program – IU Simon Comprehensive Cancer Center
IU Simon Comprehensive Cancer Center/LinkedIn
Mar 5, 2025, 07:30

Indiana’s first mobile lung screening program – IU Simon Comprehensive Cancer Center

IU Simon Comprehensive Cancer Center shared a post on LinkedIn:

“Indiana’s first mobile lung screening program, which includes a 40-foot truck with a CT scanner, is bringing life-saving lung screenings directly to Hoosiers across the state. The program will offer a convenient and accessible way to detect lung cancer early, when it is most treatable.

Learn more.”

IU Simon Comprehensive Cancer Center

cancer IU Simon Comprehensive Cancer Center lung screening program OncoDaily Oncology
Special Coverage
Blog
Apr 4, 2025, 20:41
Michael Sapienza: Colorectal Cancer Alliance is hiring a VP of Data Intelligence and Technology
Science
Apr 4, 2025, 20:29
Gaëlle Saint-Hilary: Benefit-risk assessment of ivosidenib vs. placebo in mIDH1 cholangiocarcinoma
Blog
Apr 4, 2025, 20:12
David Planchard: A pleasure to discuss diagnostic and therapeutic advances in EGFR lung patients in Cannes
Science
Apr 4, 2025, 19:52
Paolo Bossi: Immunotherapy plus cetuximab in advanced/metastatic cutaneous squamous cell carcinoma
Blog
Apr 4, 2025, 19:34
Matthew Kurian: The barriers to AI adoption in oncology
Blog
Apr 4, 2025, 19:19
Michaela Cada: Proud to be part of the SickKids family for 20 years
Blog
Apr 4, 2025, 19:05
Laurence Albiges: Day 1 of ESMO Preceptorship in metastatic urothelial RCC cancer
Blog
Apr 4, 2025, 18:55
The invisible killer in your lungs - Pink Hearts Cancer Support Foundation
Blog
Apr 4, 2025, 18:54
Yelak Biru: How pharma medical affairs and innovation teams can learn from Myelo’s AI journey
Insight
Apr 4, 2025, 18:36
Luis Lara-Mejía: Neoadjuvant aumolertinib converted 45.1% of unresectable stage III EGFRm NSCLC to resectable status
Insight
Apr 4, 2025, 18:06
Hypofractionated Radiotherapy for Soft Tissue Sarcomas
Blog
Apr 4, 2025, 17:45
Raj Batra: The absence of scientific rationale underlying contemporary clinical trials in lung cancers